KalVista Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Framingham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
KalVista Pharmaceuticals, Inc. has filed 884 SEC EDGAR filings since 29 Dec 2005

SEC filing history

Showing 576-600 of 882 matching filings.

Per page
25
Current page
24
SC 13D/A File 005-88797

SC 13D/A

Filing date
24 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36830

8-K FOR DAN SOLAND APPOINTMENT

Filing date
24 Apr 2019
Reporting date
18 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Apr 2019
Reporting date
22 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Apr 2019
Reporting date
15 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Apr 2019
Reporting date
22 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
23 Apr 2019
Reporting date
22 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Apr 2019
Reporting date
18 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88797

SC 13G filing

Filing date
19 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Apr 2019
Reporting date
17 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88797

SCHEDULE 13D AMENDMENT NO. 2

Filing date
15 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Apr 2019
Reporting date
08 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Apr 2019
Reporting date
05 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88797

SC 13D/A

Filing date
03 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Apr 2019
Reporting date
29 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36830

8-K

Filing date
29 Mar 2019
Reporting date
29 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-228831

424B5

Filing date
29 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Mar 2019
Reporting date
26 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88797

SCHEDULE 13D/A (AMENDMENT NO. 3)

Filing date
20 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Mar 2019
Reporting date
18 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Mar 2019
Reporting date
18 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Mar 2019
Reporting date
14 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36830

8-K

Filing date
14 Mar 2019
Reporting date
14 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-230279

S-8

Filing date
14 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36830

Q3-19 10-Q

Filing date
14 Mar 2019
Reporting date
31 Jan 2019
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Mar 2019
Reporting date
04 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .